Description of the blood test:

The Fluorescent Antinuclear Antibody (FANA) test is the primary “searchlight” used to screen for systemic autoimmune diseases. It detects antibodies that mistakenly target the nucleus of the body’s own cells. Using a technique called Indirect Immunofluorescence (IIF) on specialized “HEp-2” cells, laboratory specialists can see not only if these antibodies are present but also the specific “pattern” they create. This pattern provides a vital clue as to which specific autoimmune disease might be active.

What Does the Test Represent?

• Goal: To detect and measure the titer (concentration) of antinuclear antibodies and identify their staining pattern.
• Main Application: Screening for Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome, Scleroderma, and Mixed Connective Tissue Disease.
• Method: Indirect Immunofluorescence (IIF).

Collection Recommendations (General)

• Timing: Morning collection is preferred.
• Fasting: Overnight fasting (8–12 hours) is recommended; plain water is allowed.
• Material: Venous blood (serum).
• Specific Rules: Avoid heavy exercise for 24 hours. Inform your doctor about any medications (such as hydralazine, procainamide, or isoniazid), as certain drugs can induce the production of these antibodies, leading to “Drug-Induced Lupus.”

Factors Influencing the Result

• Age and Health: Up to 5-15% of perfectly healthy people (especially the elderly) can have a low-positive ANA without any disease.
• Infections: Recent viral or bacterial infections can cause a temporary rise in ANA.
• Thresholds: A result of 1:40 or 1:80 is often considered a “low positive” and may not be clinically significant, whereas titers of 1:160 or 1:320 are much more likely to indicate an underlying condition.

When to Take This Test?

• Recommendations: If you have symptoms such as unexplained fever, persistent joint pain, a “butterfly-shaped” rash across the cheeks, extreme fatigue, or sensitivity to sunlight.
• Importance: This is usually the first test ordered by a rheumatologist; if the ANA is negative, many other systemic autoimmune diseases become highly unlikely.

Medical Interpretation

• Crucial Note: A positive ANA is not a diagnosis on its own; it is a “signpost” that points toward a diagnosis. Only a specialist can “fine-tune” these results by combining the titer and pattern with your specific clinical symptoms.
• Patterns:
  • Homogeneous: Often seen in SLE.
  • Speckled: Common in SLE, Sjögren’s, or Mixed Connective Tissue Disease.
  • Centromere: Highly associated with Limited Scleroderma (CREST syndrome).
  • Nucleolar: Often linked to Systemic Sclerosis.

Possible Further Investigations

• ANA Profile (ENA Panel): To identify the specific targets (like anti-dsDNA, anti-Ro, anti-La, anti-Sm).
• CRP and ESR: To measure the level of systemic inflammation.
• Complement Levels (C3, C4): To check if the immune system is actively consuming its resources.
• Urinalysis: To screen for kidney involvement (common in Lupus).
• Consultation with a Rheumatologist.

When Does the Next Step Make Sense?

• If the FANA test is positive at a significant titer (usually 1:160 or higher), the next step is almost always a more specific “ENA Profile” to find out exactly which antibody is present. This helps the doctor confirm the specific disease and start the correct treatment to protect the organs.
• All clinical decisions must be made by a healthcare professional based on the physical exam and laboratory data.

👉 If necessary, you can discuss the analysis results with a specialist such as a rheumatologist (Doctors – TAMC).